DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Miao B, Sood N, Bunz TJ, Coleman CI.
Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysis.
Eur J Haematol 2020;
104 (04) 328-335
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.